Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression

Journal of General Internal Medicine

Volumn 19, Issue 8, 2004, Pages 828-834

  Cox, Lisa Sanderson ^a   Patten, Christi A ^a,b,d   Niaura, Raymond S ^e   Decker, Paul A ^d   Rigotti, Nancy ^f   Sachs, David P L ^g   Sonia Buist, A ^h   Hurt, Richard D ^a,c  

^a Nicotine Dependence Ctr Res Prog   (United States)

^b Dept of Psychiatry and Psychology ^*  (United States)

^c Division of Community Internal Medicine   (United States)

^d MAYO CLINIC   (United States)

^e BROWN UNIVERSITY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g Palo Alto Center for Pulmonary Disease Prevention   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Bupropion therapy; Major depression; Relapse prevention; Smoking

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; PLACEBO;

ADULT; ANAMNESIS; ARTICLE; BECK DEPRESSION INVENTORY; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVALUATION; EXPIRED AIR; FEMALE; HUMAN; INFORMATION PROCESSING; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOMES RESEARCH; PHARMACEUTICAL CARE; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SELF REPORT; SMOKING; SMOKING CESSATION; SYMPTOM;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 4143147542     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2004.30423.x     Document Type: Article

References (21)

1. Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA. 1988;259:2863-6.
2. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284:2606-10.
3. Covey LS, Glassman AH, Stetner F, Becker JT. Effect of history of alcoholism or major depression on smoking cessation. Am J Psychiatry. 1993;150:1546-7.
4. Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA. 1990;264:1546-9.
5. Hayford KE, Patten CA, Rummans TA, et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry. 1999;174:173-8.
6. Niaura R, Britt DM, Borrelli B, Shadel WG, Abrams DB, Goldstein MG. History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob Res. 1999;1:251-7.
7. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001;357:1929-32.
8. Tsoh JY, Humfleet GL, Munoz RF, Reus VI, Hartz DT, Hall SM. Development of major depression after treatment for smoking cessation. Am J Psychiatry. 2000;157:368-74.
9. Thorsteinsson HS, Gillin JC, Patten CA, et al. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology. 2001;24:350-8.
10. Hays JT, Hurt RD, Rigotti N, et al. A randomized controlled trial of sustained-release bupropion for pharmacologic relapse prevention following smoking cessation. Ann Intern Med. 2001;135:423-33.
11. Glynn TJ, Manley MW. How to Help Your Patients Stop Smoking: A National Cancer Institute Manual for Physicians. Bethesda, Md: National Cancer Institute, NIH Publication No. 90-3064; 1990.
12. Spitzer RL, Williams JBW, Gibbon M, et al. User's Guide for the Structured Clinical Interview for DSM-III-R: SCID. Washington, DC: American Psychiatric Press, Inc.; 1990.
13. American Psychiatric Association. Diagnostic and Statistical Manual - Revised. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
14. Swensen WM, Morse RM. The use of a self-administered alcoholism screening test (SAAST) in a medical center. Mayo Clin Proc. 1975; 50:204-8.
15. Davis LJ. (2000). Self-administered Alcoholism Screening Test (SAAST). In: Maruish ME, ed., Handbook of Psychological Assessment in Primary Care Settings. Mahweh, NJ: Lawrence Erlbaum; 2000:537-54.
16. Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3:235-41.
17. Beck AT, Steer RA. Beck Depression Inventory. Philadelphia, Pa: Center for Cognitive Therapy; 1987.
18. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford: Clarendon Press; 1994.
19. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
20. Hays JT, Schroeder DR, Offord KP, et al. Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med. 1999;21:244-50.
21. Hall SM, Reus VI, Munoz RF, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998;55:683-90.